IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $70,000 | +2.9% | 14,657 | -2.6% | 0.02% | +12.5% |
| Q2 2022 | $68,000 | -5.6% | 15,046 | -0.4% | 0.02% | +14.3% |
| Q1 2022 | $72,000 | -45.9% | 15,106 | -15.5% | 0.01% | -39.1% |
| Q4 2021 | $133,000 | +30.4% | 17,887 | -0.8% | 0.02% | +35.3% |
| Q3 2021 | $102,000 | -14.3% | 18,027 | -0.7% | 0.02% | -15.0% |
| Q2 2021 | $119,000 | -22.2% | 18,159 | -3.7% | 0.02% | -23.1% |
| Q1 2021 | $153,000 | +22.4% | 18,866 | -2.7% | 0.03% | +23.8% |
| Q4 2020 | $125,000 | +76.1% | 19,397 | -1.0% | 0.02% | +61.5% |
| Q3 2020 | $71,000 | -31.1% | 19,589 | -12.3% | 0.01% | -31.6% |
| Q2 2020 | $103,000 | +51.5% | 22,325 | +11.6% | 0.02% | +35.7% |
| Q1 2020 | $68,000 | -20.9% | 20,011 | +19.1% | 0.01% | 0.0% |
| Q4 2019 | $86,000 | +75.5% | 16,808 | -18.3% | 0.01% | +75.0% |
| Q3 2019 | $49,000 | +8.9% | 20,577 | -0.9% | 0.01% | 0.0% |
| Q2 2019 | $45,000 | – | 20,762 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |